Published Articles & Presentations

The information in our publications and presentations should be considered accurate only as of the date of the publications or presentations. We disclaim any obligation to supplement or update the information in these publications and presentations.

To learn more about our innovative technology:

Publications Presentations

Impact and Burden of Episodic, Acute Migraine (I-BEAM) A Patient Experience Study

Presented at the 2020 Diamond Headache Clinic Research & Educational Foundation (DHCREF) Virtual Meeting: The New Paradigm of Treatment for the Headache Patient Authors: Sutapa Ray, Sheena K. Aurora, John Hoekman, Stephen B. Shrewsbury Objective: To better understand: 1) To…

Cardiovascular Profile of Dihydroergotamine Mesylate (DHE) Delivered by INP104 Compared to D.H.E. 45® for Injection From the INP104-101 Clinical Trial

Presented at the 2020 Diamond Headache Clinic Research & Educational Foundation (DHCREF) Virtual Meeting: The New Paradigm of Treatment for the Headache Patient Authors: Karen Craig, John Hoekman, Maria Jeleva, Kelsey Satterly, Stephen Shrewsbury Background: DHE is effective for acute migraine. The approved…

Patient Acceptability of a Novel Upper Nasal Delivery System for Dihydroergotamine Mesylate Using the Precision Olfactory Delivery (POD®) Device – Results From the Open-label STOP 301 Trial

Poster presented at the 2020 American Headache Society (AHS) Virtual Annual Scientific Meeting. Authors: Stephen B. Shrewsbury, John Hoekman, Maria Jeleva. Objective: To report the safety, tolerability, exploratory efficacy, and patient acceptability of POD DHE mesylate (INP104) over 24 weeks…

19 20 21